• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑秃患者血清总IgE水平升高与临床特征之间的相关性。

Correlation between increased total serum IgE levels and clinical features in alopecia areata patients.

作者信息

Sun Yijie, Xu Shuang, Zhang Yujing, Wang Yuxin, Zhang Jianzhong, Li Xiangqian, Zhou Cheng

机构信息

Peking University People's Hospital, Department of Dermatology, Beijing, China.

Peking University People's Hospital, Department of Clinical Laboratory, Beijing, China.

出版信息

Front Immunol. 2025 Jun 2;16:1581976. doi: 10.3389/fimmu.2025.1581976. eCollection 2025.

DOI:10.3389/fimmu.2025.1581976
PMID:40529372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12171167/
Abstract

BACKGROUNDS

Alopecia areata (AA) is primarily associated with a Type 1 (Th1) inflammatory response, but emerging evidence also suggests a potential contribution of Type 2 (Th2) immunity. However, the relationship between IgE levels and pathogenesis of AA, as well as its clinical features, remains unclear, with limited and conflicting evidence in current research. This study aims to compare the total serum IgE levels between AA patients without atopic diseases and healthy controls, and to examine the correlation of IgE levels with gender, age, disease severity, disease duration, and affection of eyebrows, eyelashes, and nails.

METHODS

AA patients without other hair loss diseases and conditions, or systemic treatment known to affect serum IgE were included. Medical records of 436 patients and 181 normal controls were retrospectively analyzed between May 2018 and November 2024. Among AA patients, clinical features and total serum IgE levels were analyzed.

RESULTS

The elevated total serum IgE rate was observed in 31.0% of AA patients, which was significantly higher than that in control groups (P < 0.001). Among AA patients, total serum IgE levels differed significantly by gender (P = 0.002), age (P < 0.001), and disease severity (P = 0.040). Patients with alopecia universalis or totalis (AU/AT) had higher total serum IgE levels compared to those with localized AA (P = 0.049). No significant correlation was found between total serum IgE levels and disease duration.

CONCLUSIONS

Our research reveal that total serum IgE levels are elevated in AA patients compared to control group. Male patients, children, and individuals with moderate-severe AA patients showed significantly higher IgE levels. These results suggest the involvement of IgE and Th2 cytokines in AA pathogenesis.

摘要

背景

斑秃(AA)主要与1型(Th1)炎症反应相关,但新出现的证据也表明2型(Th2)免疫可能发挥作用。然而,IgE水平与AA发病机制及其临床特征之间的关系仍不明确,目前研究中的证据有限且相互矛盾。本研究旨在比较无特应性疾病的AA患者与健康对照者的血清总IgE水平,并探讨IgE水平与性别、年龄、疾病严重程度、病程以及眉毛、睫毛和指甲受累情况的相关性。

方法

纳入无其他脱发疾病及已知会影响血清IgE的全身治疗的AA患者。回顾性分析了2018年5月至2024年11月期间436例患者和181例正常对照的病历。对AA患者的临床特征和血清总IgE水平进行了分析。

结果

31.0%的AA患者血清总IgE水平升高,显著高于对照组(P < 0.001)。在AA患者中,血清总IgE水平在性别(P = 0.002)、年龄(P < 0.001)和疾病严重程度(P = 0.040)方面存在显著差异。泛发性或全秃性斑秃(AU/AT)患者的血清总IgE水平高于局限性AA患者(P = 0.049)。血清总IgE水平与病程之间未发现显著相关性。

结论

我们的研究表明,与对照组相比,AA患者的血清总IgE水平升高。男性患者、儿童以及中重度AA患者的IgE水平显著更高。这些结果提示IgE和Th2细胞因子参与了AA的发病机制。

相似文献

1
Correlation between increased total serum IgE levels and clinical features in alopecia areata patients.斑秃患者血清总IgE水平升高与临床特征之间的相关性。
Front Immunol. 2025 Jun 2;16:1581976. doi: 10.3389/fimmu.2025.1581976. eCollection 2025.
2
Incidence, stage and outcome of malignant melanoma, keratinocyte and other cancers in individuals with vitiligo or alopecia: intraindividual or familial risks?白癜风或斑秃患者中恶性黑色素瘤、角质形成细胞癌及其他癌症的发病率、分期和预后:个体内或家族性风险?
Br J Dermatol. 2025 Jun 20;193(1):66-73. doi: 10.1093/bjd/ljaf074.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study.约旦患者中 Janus 激酶抑制剂治疗脱发的疗效:一项回顾性队列研究。
Cureus. 2025 May 18;17(5):e84321. doi: 10.7759/cureus.84321. eCollection 2025 May.
5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
6
CALCULATION OF TOTAL ENERGY EXPENDITURE IN ADULTS WITH CROHN'S DISEASE BY INDIRECT CALORIMETRY AND SIMPLE WEIGHT-BASED EQUATIONS: A COMPARATIVE STUDY.通过间接测热法和基于体重的简单公式计算克罗恩病成年患者的总能量消耗:一项对比研究
Arq Gastroenterol. 2025 Jun 16;62:e24122. doi: 10.1590/S0004-2803.24612024-122. eCollection 2025.
7
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
8
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
9
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
10
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.

本文引用的文献

1
Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of The Literature.度普利尤单抗与斑秃:一种可能的联合治疗或干扰治疗?文献综述
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024270. doi: 10.5826/dpc.1404a270.
2
IgE-FcεRI protein-protein interaction as a therapeutic target against allergic asthma: An updated review.IgE-FcεRI蛋白-蛋白相互作用作为过敏性哮喘的治疗靶点:最新综述
Int J Biol Macromol. 2025 Jan;284(Pt 1):138099. doi: 10.1016/j.ijbiomac.2024.138099. Epub 2024 Nov 26.
3
British Association of Dermatologists living guideline for managing people with alopecia areata 2024.英国皮肤科医师协会2024年斑秃患者管理实用指南
Br J Dermatol. 2025 Jan 24;192(2):190-205. doi: 10.1093/bjd/ljae385.
4
Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata.斑秃对 JAK 抑制剂反应不足的预测因素和管理。
Am J Clin Dermatol. 2024 Nov;25(6):975-986. doi: 10.1007/s40257-024-00884-x. Epub 2024 Sep 3.
5
Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.过敏治疗中的治疗性单克隆抗体:靶向IgE、细胞因子和警报素途径。
Immunol Rev. 2024 Nov;328(1):387-411. doi: 10.1111/imr.13380. Epub 2024 Aug 19.
6
Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study.度普利尤单抗可诱导儿童斑秃毛发再生:一项真实世界、单中心观察性研究。
Arch Dermatol Res. 2024 Jul 23;316(7):487. doi: 10.1007/s00403-024-03225-4.
7
Dupliumab therapy for alopecia areata: a case series and review of the literature.度普利尤单抗治疗斑秃:病例系列及文献综述
J Dermatolog Treat. 2024 Dec;35(1):2312245. doi: 10.1080/09546634.2024.2312245. Epub 2024 Feb 11.
8
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.特应性皮炎(湿疹)的全身治疗:随机试验的系统评价和网状Meta分析
J Allergy Clin Immunol. 2023 Dec;152(6):1470-1492. doi: 10.1016/j.jaci.2023.08.029. Epub 2023 Sep 9.
9
Biomarkers in alopecia Areata: A systematic review and meta-analysis.斑秃的生物标志物:系统评价和荟萃分析。
Autoimmun Rev. 2023 Jul;22(7):103339. doi: 10.1016/j.autrev.2023.103339. Epub 2023 Apr 20.
10
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation.奥马珠单抗、美泊利珠单抗和度匹鲁单抗治疗哮喘的疗效比较:一项目标试验模拟。
J Allergy Clin Immunol. 2023 May;151(5):1269-1276. doi: 10.1016/j.jaci.2023.01.020. Epub 2023 Feb 3.